EVALUATION OF IMMUNOTOXICITY OF THE THERAPEUTIC DRUG PROLONGED ACTION FOR MULTIPLE SCLEROSIS ON RHESUS MONKEYS
This article presents the results of immunotoxicity study of a novel slow-release drug for multiple sclerosis treatment based on recombinant human interferon beta-1а. The test article is polyethylene glycol (PEG)-conjugated interferon beta-1a. Performed modification allows to improve pharmacokinetic...
Guardado en:
Autores principales: | A. B. Dzheliya, Ya. Yu. Ustyugov, M. A. Kortava |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/572806fba477489c9191f0392523ba81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ESTRIOL IN FUNCTIONAL MODULATION OF REGULATORY LYMPHOCYTES IN MULTIPLE SCLEROSIS
por: I. V. Nekrasova, et al.
Publicado: (2014) -
Células natural killer y el sistema inmune innato en la patología infecciosa
por: Sepúlveda C,Cecilia, et al.
Publicado: (2000) -
T–CELL VACCINE PREPARATION FOR MULTIPLE SCLEROSIS TREATMENT
por: I. P. Ivanova, et al.
Publicado: (2014) -
LYMPHOCYTE SUBSETS, IMMUNOGLOBINS AND HUMAN LEUCOCYTE ANTIGENS OF 1-ST CLASS IN PATIENTS WITH ENDOMETRIOSIS
por: E. A. Celuba, et al.
Publicado: (2012) -
Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects
por: Stefanie Fischer, et al.
Publicado: (2021)